NIH Funding · FY2024
Total Funding
$3M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#2,650
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $3M across 4 grants · National rank #2650.
Top grants by award amount
Edward Gomperts's NIH grant portfolio, ranked by award amount.
- 5R44HL131065-06R44HBI-002 to Prevent Vaso-Occlusive Crises in Sickle Cell Disease$999.9Kaward amount
- $950.2Kaward amount
- 4UH3NS127943-02UH3Oral N2O Therapy in Treating Acute Vaso-Occlusive Pain in Sickle Cell Disease$728.1Kaward amount
- $300Kaward amount
Affiliation
Institutions that have administered grants for Edward Gomperts.
Affiliated with Hillhurst Biopharmaceuticals, Inc. (CA).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardHillhurst Biopharmaceuticals, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #2650
- 2024Entered Top 25% NationallyRanked #2650
Related investigators
Other NIH-funded PIs frequently associated with Edward Gomperts.
Explore further
Find collaborators for Edward Gomperts
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Hillhurst Biopharmaceuticals, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →